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ABSTRACT
Introduction: Neuraxial (spinal) anesthesia is a favored modality in the care of obstetric patients
undergoing a cesarean-section (C-section). Spinal anesthesia is additionally popular as an
alternative method for various surgical procedures in non-obstetric patients allowing
practitioners to avoid potential risks associated with the use of general anesthesia. Spinal
anesthesia-induced hypotension (SAIH) is a common side effect that presents status postinitiation of spinal anesthesia. The source of the hypotension produced after the initiation of
spinal anesthesia is due to inhibition of the sympathetic nervous system (sympathectomy) and
bradycardia caused by stimulation of the Bezold-Jarisch Reflex. A relatively new intervention
that practitioners are using to mitigate the stimulation of the Bezold-Jarisch Reflex is the use of
5-HT3 receptor antagonists. Ondansetron is a 5-HT3 receptor antagonist implicated in
decreasing the incidence and severity of SAIH.
Objective: The purpose of this literature review was to examine the efficacy of the prophylactic
administration of ondansetron (5-HT3 receptor antagonist) before induction of spinal anesthesia
in the attenuation of the incidence of SAIH. The hypothesis used in this research study was :
Does Prophylactic Administration Of Ondansetron Prior To Spinal Anesthesia Decrease SpinalAnesthesia Induced Hypotension In Obstetric And Non-Obstetric Patients”:
Methodology: The current literature review attempts to identify recent studies on the use of
prophylactic ondansetron before spinal anesthesia and its ability to decrease the incidence of
SAIH. Databases which included: PUB-MED, Academic Search Premier, EBSCO Host, and
Google-Scholar were searched for randomized control trials (RCTs) investigating the effects of
ondansetron and its ability to attenuate SAIH. The principal outcome of the focus for this review
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was the incidence of hypotension after the initiation of spinal anesthesia. PRISMA guidelines
and the Cochrane Risk of Bias Tool influenced the design and data collection of this review.
Results: Eleven studies (Five non-obstetric and six obstetric) consisting of 1,257 patients (nonobstetric n = 616, Obstetric n = 641) categorized by the American Society of Anesthesiology
(ASA) class I-III were included in this review. Three out of five non-obstetric-group studies
support the hypothesis of this literature review and concluded that prophylactic ondansetron
administered before spinal anesthesia was effective in decreasing the incidence of hypotension
compared to a placebo. Three out of six obstetric group studies also supported the hypothesis of
this literature review and concluded that prophylactic ondansetron before spinal anesthesia was
effective in decreasing the incidence of hypotension when compared to a placebo.
Discussion/Conclusion: The results of this literature review show that the prophylactic
administration of ondansetron before induction of spinal-anesthesia does not clearly inhibit
stimulation of the BJR or significantly decrease the incidence of SAIH in obstetric and nonobstetric patients. Additional studies are needed focusing on uniformity in testing so there can
be stronger correlations in comparing results, and thus more definitive conclusions can be made.
Keywords: Bezold-Jarisch reflex, Ondansetron, serotonin, spinal-anesthesia induced
hypotension, 5-HT3 receptors.
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INTRODUCTION
Neuraxial(spinal) anesthesia is a popular modality used for the management of obstetric
patients undergoing cesarean section (C-Section). Hypotension is a familiar and predictable
event anticipated in the obstetric patient undergoing spinal anesthesia (Hasanin, Mokhtar,
Badawy, & Fouad, 2017). Complications that may arise in the mother and newborn as a result
of Spinal Anesthesia-Induced Hypotension (SAIH) include nausea and vomiting and
cardiovascular collapse in the parturient and decreased perfusion and acidosis in the fetus due to
compromised uteroplacental blood flow as a result of maternal hypotension (Barash et al., 2017).
Spinal anesthesia is also considered safe for use in the non-obstetric population for many
procedures in patients who may be at increased risk of adverse events associated with the
administration of general anesthesia. Furthermore, complications that may arise in the nonobstetric patient in response to SAIH include but are not limited to decreased perfusion of vital
organs and tissues, and the potential for cardiovascular collapse (Nagelhout & Sass, 2018). The
prevalence of hypotension found in the obstetric population is as high as 75% of cases and in the
non-obstetric population prevalence is open for debate due to multiple factors but has been found
as high as 70% in the elderly (Owczuk et al., 2015; Šklebar, Bujas, & Habek, 2019). The two
main factors that influence the incidence of hypotension after initiation of spinal anesthesia are:
first, how hypotension is defined, and second, the amount (dose) of Local Anesthetic (LA)
administered intrathecally (Lee, George, & Habib, 2017). The definition of hypotension varies
and can be confusing when trying to compare the incidence of hypotension reported among
different studies. The literature has revealed that researchers have used as many as fifteen
different definitions of hypotension in their studies (Klohr, Roth, Hofmann, Rossaint, & Heesen,
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2010). Though a consensus definition of hypotension is not currently accepted, it is referenced
most often in correlation with a patient’s systolic blood pressure (Carpenter, Caplan, Brown,
Stephenson, & Wu, 1992). Despite the variance amongst studies, the most common definition of
hypotension used in the literature is a drop in baseline blood pressure of 20% or higher (Habib,
2012).
In reference to the incidence of hypotension being dependent on the amount of local
anesthetic administered intrathecally. Using low-doses of Bupivacaine (5-7 mg) for the
management of C-section via spinal anesthesia has been shown to reduce the severity of
hypotension and the adverse effects of SNS depression (Roofthooft & Van de Velde, 2008). It is
important to note that decreasing the amount of LA to decrease the severity of sympathectomy
elicits undesired consequences such as the need for increased intraoperative analgesia
requirement and slower onset and decreased duration of spinal block (Arzola & Wieczorek,
2011);(McNaught & Stocks, 2007). The increased analgesic requirement is a concern because
many drugs used for intraoperative pain control can cause cardiac depression, possibly negating
any benefit from decreasing the amount of LA administered intrathecally (Flood, Rathmell, &
Shafer, 2015). Other factors that may also influence the frequency and severity of hypotension
in patients undergoing spinal anesthesia are a result of a diverse population in reference to an
individual patient's personal medical history, including comorbidities and the anesthesia
technique administered (Tubog, Kane, & Pugh, 2017). In order to manage hypotension and to
prevent the possible adverse complications that may arise as result, anesthesia providers have
developed strategies to both prevent and treat SAIH. These strategies included using fluid
preloading/co-loading to augment venous pressure, leg compression to optimize venous return,
and positioning using left uterine displacement to prevent aortocaval compression of the great
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vessels (Nagelhout & Sass, 2018) These modalities are still used today as part of the anesthetic
management of SAIH. However, they are minimally effective in the treatment of SAIH, thus
weakening the claim that aortocaval compression and venous pooling in the lower extremities
are the primary causes of hypotension (Lee et al., 2017). Moreover, evidence from multiple
studies has indicated that after initiation of spinal anesthesia, heart rate and stroke volume
increase for the first 15 minutes, improving CO (Dyer et al., 2009; Langesaeter, Rosseland, &
Stubhaug, 2008). During this same period, there is a significant drop in systemic vascular
resistance (), underscoring the notion that a reduction of arterial tone is the probable source of
hypotension (Langesaeter et al., 2008; Sharwood-Smith & Drummond, 2009). As a result, antihypotensive drugs (vasopressors) are popular and are the foundation for the management of
SAIH (Barash et al., 2017)
The management of SAIH was the primary focus of anesthesia practitioners for an
extended period. In response to additional information that has been made available on the
processes that lead to SAIH, prevention once again is the focus. The Bezold-Jarisch Reflex
(BJR) is suspected to be critical in cascading events that occur after spinal anesthesia, leading to
bradycardia and hypotension (Flood et al., 2015). An immediate response with interventions
aimed at remedying these adverse events of bradycardia and hypotension are essential;
otherwise, cardiovascular collapse may ensue (Campagna & Carter, 2003). The BJR is a
cardioinhibitory reflex controlled by unmyelinated (type-C) nerve fibers residing in the heart
(Campagna & Carter, 2003; Flood et al., 2015). The BJR activates via agonism of peripheral
serotonin 5-hydroxytryptamine (5-HT3) receptors (Martinek, 2004).
To prevent the stimulation of the BJR and, subsequently, the bradycardia and hypotension
that follows, antagonism of peripheral 5-HT3 receptors has been a focus of exploration.
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Ondansetron is a frequent agent used in anesthesia for prevention as well as treatment of
postoperative nausea and vomiting. Ondansetron is also a 5-HT3 receptor antagonist and has
been the most widely studied 5-HT3 receptor antagonist used to potentially attenuate SAIH and
bradycardia (Tubog et al., 2017). This literature review of Randomized Control Trials (RCTs)
recognized if the prophylactic administration of intravenous (IV) ondansetron before initiation of
spinal anesthesia is effective in decreasing the incidence of hypotension.
The purpose of this literature review was to examine the efficacy of the prophylactic
administration of ondansetron (5-HT3 receptor antagonist) before induction of spinal anesthesia
in the attenuation of the incidence of SAIH.

METHODOLOGY
Research Hypothesis: The hypothesis used in this research study was : Does Prophylactic
Administration Of Ondansetron Prior To Spinal Anesthesia Decrease Spinal-Anesthesia Induced
Hypotension In Obstetric And Non-Obstetric Patients”:
Literature Review: The databases, including PubMed, EBSCO Host, Google Scholar, and
Academic Search Premier, were utilized without filters or language restrictions for studies
conducted from 1992 and 2020 in the English language. The following [MeSH Terms] WERE
used: (obstetric OR non-obstetric) AND (("Anesthesia, Spinal") AND (Hypotension) AND
(Ondansetron). The bibliographies of articles were retrieved and utilized to identify potential
studies for inclusion in this review. The Cochrane Handbook for Systematic Reviews helped to
prevent/limit selection bias based on the methodological approach used in the studies screened
for inclusion in this review (Higgins, Thomas, Cumpston, Li, & Page, 2019). The literature
review design followed the Preferred Reporting Items for Systematic Reviews and Meta-
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Analyses (PRISMA) flowchart(Moher, Liberati, Tetzlaff, & Altman, 2009). The initial search
found 158 articles an additional nine articles found through bibliographies. After removing
duplicates, 136 abstracts got screened for potential inclusion in the current study. One-hundred
and twenty of these articles were immediately excluded based as they did not follow to the
purpose of this literature review. Nine-teen articles were relevant to the purpose of this
assessment, but only sixteen articles had a full-text available (See figure 1). The full-text articles
additionally received an evaluation for the risk of bias (RoB) using the Cochrane RoB tool. To
be included in the qualitative analysis, articles had to score a low RoB in at least five of the
seven categories listed by Cochrane (see Table 1). Only eleven articles (5 non-obstetric, and six
obstetric) were deemed to meet this standard and were included in the results section of this
review (see Tables 2 and 3). Abstracts did not get included in this study. The Chi-Square test
was used amongst the different studies to compare the incidence of hypotension between the
ondansetron and placebo groups. A P-value of ≦0.05 signified to be statistically significant.
RESULTS
Eleven studies (Five non-obstetric and six obstetric) consisting of 1,257 patients (non-obstetric n
= 616, Obstetric n = 641) categorized by the American Society of Anesthesiology (ASA) class IIII compromise this review (See Table 1). The purpose of the 11 studies was to determine if
ondansetron, a 5-HT3-receptor antagonist, effectively attenuates SAIH through inhibition of the
BJR, which activates via agonist of serotonin (5-HT3) receptors. The primary outcome of these
studies' focus was the incidence of hypotension after prophylactic intravenous (IV) ondansetron
was administered before spinal anesthesia compared to a placebo.
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Non-obstetric Studies: Three out of the five non-obstetric-group studies reported that
prophylactic ondansetron administered before spinal anesthesia was effective in decreasing the
incidence of hypotension compared to a placebo (See Table 2). In their study of 106 patients,
Baig et al. found that ondansetron 6 mg IV before spinal anesthesia significantly reduced the
incidence of hypotension compared to a placebo (Baig, Shah, Khurshid, Abid, & Tariq, 2017).
Only 4/53 or 7.5% of patients who were administered ondansetron developed hypotension
compared to 15/53 or 28.3% of patients who received a placebo (P = 0.005) (Baig et al., 2017).
In a study of 100 patients, Shah et al. found that ondansetron 8 mg IV before spinal anesthesia
significantly reduced the incidence of hypotension compared to a placebo (Shah, Naqvi, &
Abbas, 2019). In their study, 23/50 or 46% of patients receiving ondansetron developed
hypotension compared to 36/50 or 72% of patients who received a placebo (P = 0.026). Marashi
et al. .in a study of 210 patients found that ondansetron 6 mg and 12 mg of ondansetron IV given
before spinal anesthesia significantly reduced the incidence of hypotension compared to a
placebo (Marashi, Soltani-Omid, Soltani Mohammadi, Aghajani, & Movafegh, 2014). In their
study, there were no patients who received ondansetron that developed hypotension compared to
12/70 or 17% of patients who received a placebo (P = 0.04)
In contrast, there were two among the non-obstetric-group studies included in this review
that did not find ondansetron to be Statistically significantly effective in decreasing the incidence
of hypotension compared to a placebo (See Table 2). Bommala et al., in a study of 60 patients,
found that ondansetron 4 mg IV before spinal anesthesia did not sufficiently decrease the
incidence of hypotension compared to a placebo (Bommala et al., 2019). In their study, 7/30 or
24.3% of patients who received ondansetron developed hypotension compared to 14/30 or 46%
of patients receiving a placebo (P= 0.079) Tatikanda et al., in a study of 140 patients, also did not
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find that 4 mg of ondansetron IV before spinal anesthesia significantly reduced the incidence of
hypotension compared to a placebo (Tatikonda et al., 2019). In their study, they reported that
17/70 or 24.3% of patients given ondansetron developed hypotension compared to 23/70 or
32.9% of patients receiving a placebo (P > 0.05)
Obstetric studies: Three out of SIX studies obstetric group studies determined that prophylactic
ondansetron before spinal anesthesia was effective in decreasing the incidence of hypotension
when compared to a placebo (See Table 3.). Abbas et al., in a study of 100 patients, found that 4
mg of ondansetron IV before spinal anesthesia significantly decreased the incidence of
hypotension when compared to a placebo (Abbas, Shah, & Naqvi, 2016). Their study found that
21/50 or 42% of patients given ondansetron exhibited hypotension compared to 34/50 or 72% of
patients given a placebo (P = 0.009) (Abbas et al., 2016). Sahoo et al., in a study of 52 patients,
reported that 4 mg of ondansetron IV before spinal anesthesia was successful in decreasing the
incidence of hypotension when compared to a placebo (Sahoo, SenDasgupta, Goswami, &
Hazra, 2012). In their study, they found that 2/26 or 8% of patients receiving ondansetron
developed hypotension compared to 11/26 or 42% of patients who received a placebo (P = 0.009)
Also, Trabelsi et al., in a study of 80 patients, found that 5 mg of ondansetron IV before spinal
anesthesia was sufficient in decreasing the incidence of hypotension compared to a placebo
(Trabelsi et al., 2015). In their study, they reported that 15/40 or 37.5% of patients who received
ondansetron developed hypotension compared to 31/50 or 77.5% of patients who received a
placebo (P < 0.001)
In contrast, there were 3 of the obstetric group studies that found that ondansetron administered
IV before spinal anesthesia was not significantly successful in attenuating the incidence of
hypotension when compared to a placebo (See Table 3.). Karacaer et al. in a study consisting of
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104 patients reported that 8 mg of ondansetron IV before spinal anesthesia was not significantly
effective in decreasing the incidence of hypotension compared to a placebo (Karacaer, Biricik,
Ünal, Büyükkurt, & Ünlügenç, 2018). In their study, they found that 47/54 or 87% of patients
administered ondansetron developed hypotension compared to 48/54 or 89% of the patients who
received a placebo (P = 0.76) (Karacaer et al., 2018). Oofuvong et al., in a study comprised of
210 patients, found that 0.05 - .1 mg/kg of ondansetron IV before spinal anesthesia did not
significantly decrease the incidence of hypotension when compared to a placebo (Oofuvong,
Kunapaisal, Karnjanawanichkul, Dilokrattanaphijit, & Leeratiwong, 2018). In their study, they
found that 60/71 or 84.5% of patients receiving .05 mg/kg and 53/72 or 73.6% of patients who
received 0.1 mg/kg of ondansetron developed hypotension compared to 59/72 patients who
received a placebo (P = 0.23) (Oofuvong et al., 2018). Terkawi et al., in a study of 86 patients,
found that 8 mg of IV ondansetron administered before spinal anesthesia was not significantly
efficient at decreasing the incidence of hypotension when compared to a placebo (Terkawi et al.,
2015). Their study found that 26/44 or 59.1% of patients who received ondansetron developed
hypotension compared to 25/42 or 59.5% of patients who received a placebo (P = 1).
Non-obstetric Studies incidence of hypotension: Incidence of hypotension in patients receiving
prophylactic ondansetron in non-obstetric patients ranged from 0% – 46% compared to 17%72% in patients receiving a placebo (See Table 2.). In the five studies reviewed in this group, all
patients 15 mg of Bupivacaine intrathecal, and one study additionally used 25 mcg of fentanyl in
combination with Bupivacaine Baig et al., Marashi et al., and Tatikonda et al. defined
hypotension as a 20% decrease in MAP from baseline or a MAP less than 80mmHg. Bommala
et al. defined hypotension as a 30% decrease in SBP from baseline or SBP less than 90 mmHg,
and Shah et al. defined hypotension as a 20% decrease in SBP or SBP less than 90 mmHg). The
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dose of ondansetron administered before spinal anesthesia also varied among the studies in this
group ranging from 4 -12 mg (See Table 2).

Obstetric Studies incidence of hypotension: Incidence of hypotension in patients receiving
prophylactic ondansetron in obstetric patients ranged from 8-87% to 42-89% in patients
receiving a placebo (See Table 3). In the six studies reviewed in this group, patients were
administered Bupivacaine intrathecal in doses ranging from 10-15mg. Also, 4/6 studies in this
group administered narcotics in combination with Bupivacaine for spinal anesthesia (See Table
3). Karacaer et al., and Abbas et al. defined hypotension as a 20% decrease in SBP from
baseline. Oofuvong et al. defined hypotension, as a greater than 30% decrease in MAP, Terkawi
et al. defined hypotension as an SBP less than 90mmHg. Trabelsi et al. defined hypotension as a
less than or equal to 20% decrease in SBP or less than 80 mmHg, and Sahoo et al. defined

hypotension as an SBP less than 90 mmHg or DBP less than 60 mmHg. The dose of

ondansetron administered before spinal anesthesia also varied in this group and ranged from 48mg (See Table 3).

DISCUSSION
The purpose of this literature review was to examine the efficacy of the prophylactic
administration of ondansetron (5-HT3 receptor antagonist) before induction of spinal anesthesia
in the attenuation of the incidence SAIH. The results of the current study are mixed regarding if
the prophylactic ondansetron did decrease the incidence of SAIH. Nearly 50 % of the studies
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included in this review reported no significant decrease in the incidence of hypotension in
patients who received ondansetron compared to those patients who received a placebo. These
findings diminish the results found in the six studies that concluded that ondansetron
significantly decreased the incidence of SAIH compared to a placebo. The different studies
show a significant amount of heterogeneity that may have played a factor in the individual
results reported.

Implications of heterogeneity amongst studies: The two most important factors that influenced
the incidence of SAIH were how hypotension was defined and how much LA was administered
intrathecal (Lee et al., 2017). Focusing on these two factors in comparing the various studies
included in this literature review highlights potential problems in drawing a definitive conclusion
when assessing the results reported. In both the no obstetric and obstetric groups, we can see
that hypotension was defined differently in both the percentage decrease from baseline and the
unit of measurement assessed as some used Mean Arterial Pressure (MAP), while others used
SBP (See Table 2,3). The dose of LA was the most congruent in the non-obstetric group as
Bupivacaine 15 mg was the dose of LA used in all the studies included, with the only exception
being that Bommala et al. added 25mcg of fentanyl to their LA (See Table 2). In the obstetric
group, all but 2 of the studies used narcotics in combination with LA in their studies.
The impact of how hypotension was defined and how impacted the incidence of
hypotension reported amongst the different groups included in this study is difficult to assess. It
is reasonable to assume that the incidence of hypotension would be lower in a study that defined
hypotension as a 30% decrease from baseline compared to a study that defined hypotension as a
20% decrease from baseline. Also, it is difficult to draw a definitive conclusion when comparing
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the results of the reported studies when more than 1 unit of measure defined hypotension, for
example, MAP vs. SBP.
The amount of LA administered intrathecal is conceptually easier to compare and draw
conclusions on how it may affect the incidence of hypotension. The side effects of most
anesthetic drugs, including LAs, are typically dose-dependent, primarily when used in
combination with other agents. The addition of opioids to the LA can increase the incidence of
SAIH as they typically decrease the sympathetic nervous system (SNS) tone (Flood et al., 2015).
For example, morphine can suppress SNS tone leading to peripheral venous dilation and
decreased venous return causing venous pooling, which ultimately results in reduced CO and
hypotension (Flood et al., 2015). Additionally, some opioids such as morphine induce histamine
release, which results in vasodilation and a subsequent drop in systemic blood pressure (Flood et
al., 2015). When comparing the results from the non-obstetric group (two out of five) studies
and the obstetric group (three out of six) studies supported the conclusion that ondansetron did
not significantly attenuate SAIH (See Table 2,3). Of these five studies, 4 used opioids in
combination with the LA, which potentially increased the incidence of SAIH and, ultimately,
their overall conclusions.
Another factor that may have influenced the incidence of SAIH reported in the studies
reviewed was the dose of ondansetron administered before spinal anesthesia. In the nonobstetric group, both of the studies that found that ondansetron did not attenuate SAIH used 4mg
of ondansetron, in the obstetric group, one third of the studies used ondansetron 4 mg and the
other 2 used a max of 8 mg. Three of three of the non-obstetric groups who reported that
ondansetron significantly attenuated the incidence of SAIH used more than 4 mg with a max of
12 mg of ondansetron (See Table 2,3). One third of the obstetric groups who found that
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ondansetron significantly attenuated the incidence of SAIH used greater than 4mg of
ondansetron; however, of the two who used 4 mg, neither used opioids in combination with the
LA (See Table 2,3).
Study Limitations: This research study was not conducted without limitations. This
literature review was restricted due to search strategy such as distinguishing differences between
keywords, number of databases accessed, or the sources used, which might have had an impact
on the quality and availability of the research. In addition, researcher and publication bias were
limitations during this study.
Another limitation is the lack of familiarity with the Cochrane RoB tool. The lack of familiarity
with this tool may have unintentionally led to selection for inclusion in this review of studies that
had more RoB and exclusion of studies that had less RoB. The lack of uniformity amongst the
different studies in this review concerning the amount of ondansetron and LA administered, and
how hypotension was defined make it difficult to draw concrete conclusions based on the results
reported.
Practical Implications: As the mixed results amongst the studies included have shown, it is
unclear that the administration of prophylactic ondansetron before spinal anesthesia attenuates
the incidence of SAIH in both obstetric and non-obstetric patients. Future studies must limit
heterogeneity and include patients receiving emergency procedures. Exploration of different
doses of ondansetron also needs further research to identify optimum ondansetron dosing.
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Conclusion
The current study results showed mixed results that the prophylactic administration of
ondansetron before spinal anesthesia was useful in the attenuation of SAIH in both obstetric and
non-obstetric patients .
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Tables
Table 1. Cochrane Risk of Bias (RoB) Tool.
Selection Bias

Author
(year)

Performance
Bias
Blinding of
participants and
personnel

Detection
Bias
Blinding of
outcome
assessment

Attrition
Bias
Incomplete
outcome data

Reporting
Bias
Selective
reporting

Other Bias

Random
sequence
generation

Allocation
concealment

Prespecified

U

U

U

U

L

L

U

L

L

L

U

L

L

U

L

L

L

U

L

L

U

L

L

L

L

L

L

U

L

L

L

L

L

L

U

U

L

L

L

L

L

U

L

U

L

U

L

L

U

L

L

L

U

L

L

U

U

L

H

H

L

L

U

L

L

L

U

L

L

U

U

U

U

L

L

L

U

L

L

L

L

L

L

U

L

L

L

L

L

L

U

L

U

L

L

L

L

U

L

L

L

L

H

L

U

L

U

L

U

L

L

U

Iqbal et al.,
2020
Bommala et
al., 2019
Shah et al.,
2019
Tatikonda et
al.,2019
Karacaer et
al., 2018
Oofuvong et
al. 2018
Raghu et al.,
2018
Baig et al.,
2017
Potdar et al.
2017
Abbas et al.,
2016
Jarineshin et
al., 2016
Terkawi et al.,
2015
Trabelsi et al.,
2015
Marashi et al.,
2014
Sahoo et al.,
2014

Wang et al.,
2014

Key: L=Low RoB, H=High RoB, U= unclear RoB
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews
of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.
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Table 2. Incidence of Hypotension Non-Obstetric Patients. Key: LA= local anesthetic,
SBP=systolic blood pressure, MAP= mean arterial pressure, % ↓ = from baseline
Author
(year)

Ondansetron
(dose)

Placebo

LA
(dose)

Definition of
hypotension

Bommala et
al., 2019

n = 30
4mg

n = 30

30% ↓ SBP
or < 90
mmHg

Shah et al.,
2019

n = 50
8mg

n = 50

Bupivacaine
(15 mg) +
25 mcg
fentanyl
Bupivacaine
(15 mg)

Tatikanda et
al., 2019

n = 70
4mg

n = 70

Bupivacaine
(15 mg)

Baig et al.,
2017

n = 53
(6mg)

n = 53

Bupivacaine
(15 mg)

Marashi et al.,
2014

n =140
6mg(n=70),
12mg(n=70)

n = 70

Bupivacaine
(15 mg)

20% ↓ SBP
or <
90mmHg
20% ↓ MAP
or <
80mmHg
20% ↓ MAP
or <
80mmHg
20% ↓ MAP
or <
80mmHg

Hypotension
Ondansetron
group
n=7
(23%)

Hypotension Significant
placebo
P≤ 0.05
group
Y/N
n = 14
P = 0.079
(46.6%
(N)

n = 23
(46%)

n = 36
(72%)

P = 0.026
(Y)

n = 17
(24.3%)

n = 23
(32.9%)

P > 0.05
(N)

n=4
(7.5%)

n = 15
(28.3%)

P = 0.005
(Y)

n=0
(0%)

n = 12
(17%)

P = 0.04
(Y)
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Table 3. Incidence of Hypotension in Obstetric Patients. Key: LA= local anesthetic,
SBP=systolic blood pressure, MAP= mean arterial pressure, % ↓ = from baseline
Author
(year)

Ondansetron
(dose)

Control
(placebo)

LA
(dose)

Karacaer et
al., 2018

n = 54
(8mg)

n = 54

Oofuvong
et al., 2018

n = 143
(.05mg/kg) = 71
(.1mg/kg) = 72
Max (8 mg)

n = 72

Bupivacaine
(10 mg) +
20 mcg
fentanyl
Bupivacaine
(10 mg) +
200 mcg
morphine

Abbas et
al., 2016
Terkawi et
al., 2015

n = 50
(4mg)
n = 44
(8mg)

n = 50

Trabelsi et
al., 2015

n = 40
(5mg)

n = 40

Sahoo et
al., 2012

n = 26
(4mg)

n = 26

n = 42

Bupivacaine
(15 mg)
Bupivacaine
(15 mg) +
20 mcg
fentanyl +
100 mcg
morphine
Bupivacaine
(10 mg) +
2.5 mcg
Sufentanil
Bupivacaine
(10 mg)

Definition
of
hypotension
20%↓ SBP

Hypotension
Ondansetron
group
n = 47
(87%)

Hypotension
placebo
group
n = 48
(89%)

Significant
if P≤ 0.05
Y/N
P = 0.767
(N)

>30% ↓
MAP

.05mg n = 60
(84.5%)
.1mg n = 53
(73.6%)

n = 59
(83%)

P = 0.23
(N)

20%↓ SBP

n = 21
(42%)
n = 26
(59.1%)

n = 34
(72%)
n = 25
(59.5%)

P = 0.009
(Y)
P=1
(N)

≦20%↓
SBP or <
80mmHg

n = 15
(37.5%

n = 31
(77.5%)

P < 0.001
(Y)

SBP < 90
mmHg or
DBP < 60
mmHg

n=2
(8%)

n = 11
(42%)

P = 0.009
(Y)

SBP <
90mmHg
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Figures

Identification

Figure 1. PRISMA 2009 Flow Diagram

Records identified through
database searching
(n = 158 )

Additional records
identified through other sources
(n = 9 )

Screening

Records after duplicates removed
(n = 136)

Records screened
(n = 136)

Full-text articles
excluded (n = 5). Scored
Low RoB in < 5/7 on
Cochrane scale
See table 1.

Studies included
qualitative synthesis
(n = 11)

Included

Eligibility

Full-text articles
assessed for eligibility
(n = 16 )

Records excluded
(n = 120)

From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and MetaAnalyses: The PRISMA Statement. PLoS Med 6(7): e1000097. DOI:10.1371/journal.pmed1000097
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